Interventional Cage Match?
Posted Jul 22, 2008
at 08:50 PM, EDT
With the release of the Xience stent in the past few days we've had a rush of device reps into the cath lab trying to outmaneuver one another to promote their products. We currently have open access to three drug eluting stents and the competition is cutthroat but very subdued.
SES have dropped off due to the release of the newer stents. ZES are less popular with the unconventional delivery system, but seem very deliverable in tight spots. EES are just out and everyone is hot to try them out, but have seen some PES-like sticky balloons.
Curious to know whether anybody else is havine a similar experience with stents or reps?
Previous postsBillets précédents
About
Welcome to the new and improved Fellows’ Corner! Our new blog engine will facilitate discussion on issues specifically geared toward cardiovascular fellows. We look forward to ongoing lively, focused and relevant discussions on issues like training, research and career planning. To suggest a topic of discussion please click the button at top right. Join in the discussion!
CommentsCommentaires
Does a "permissive" level of late loss as with EES reduce the risk of late stent thrombosis? If that is the case, then I could see EES taking over what is currently going to the BMS market.
Brian Choi, Asst Moderator